Support healthy glucose metabolism with clinically studied Calabrian bergamot polyphenols that help maintain blood sugar levels already within the normal range and promote broader metabolic balance.
Maintaining healthy blood sugar depends on how effectively the body processes glucose, responds to insulin, and converts nutrients into cellular energy. Bergamonte® has been studied across several human clinical trials that measured fasting glucose and other cardiometabolic markers, providing product developers with a research-supported botanical platform for blood sugar and metabolic wellness formulas.
Human Glucose Research
Clinical studies have measured fasting blood glucose in participants with common cardiometabolic concerns.
Defined Polyphenol Profile
Standardized to key bergamot polyphenols associated with glucose, lipid, and cellular energy pathways.
Multiple Study Durations
Human research has evaluated Bergamonte®-based ingredients across 30-, 90-, and 120-day study periods.
Cardiometabolic Context
Glucose outcomes have been evaluated alongside lipid markers, body composition, insulin resistance measures, and liver health.
Healthy blood sugar management involves more than circulating glucose alone. Insulin responsiveness, nutrient utilization, lipid metabolism, and cellular energy production all contribute to the body’s ability to maintain metabolic balance.
Key Clinical Benefits
Human clinical research has evaluated Bergamot Polyphenolic Fraction in participants with cardiometabolic concerns and reported changes in fasting blood glucose following supplementation. Bergamonte® helps maintain glucose levels already within the normal range as part of a comprehensive metabolic wellness strategy.
Insulin helps move glucose from the bloodstream into cells, where it can be used for energy. Research involving the pectin-enriched Bergamonte® BPE-C formulation evaluated HOMA-IR, a measurement associated with insulin resistance, and reported dose-responsive changes after 90 days. These findings support the ingredient’s role in formulas designed to promote healthy insulin responsiveness.
Glucose metabolism is closely connected to lipid processing, liver function, body composition, and cellular energy pathways. Bergamonte® supports this broader network through mechanisms involving AMPK activation, glucose transport, lipid metabolism, and inflammatory balance.
Human studies of bergamot polyphenol formulations have evaluated blood glucose, fasting plasma glucose and insulin sensitivity across 30-, 90- and 120-day protocols. Together, the findings provide a focused clinical view of how different studied Bergamonte® formulations relate to healthy glucose regulation and broader metabolic balance.
Why it matters: The study showed a clear dose-related glucose response.
A 120-day clinical study evaluated 38%-standardized BPF in participants with metabolic concerns. Mean fasting plasma glucose declined from 118 to 98, representing a reported 16.9% reduction over the study period.
Why it matters: The glucose response was sustained across a longer 120-day protocol.
The 90-day randomized, double-blind BPE-C study compared placebo with 650 mg/day and 1,300 mg/day. Fasting glucose changed by −1.56% with placebo, −12.08% at 650 mg/day and −18.00% at 1,300 mg/day, showing a dose-responsive pattern.
Why it matters: Higher BPE-C intake produced the strongest fasting-glucose response.
The same 90-day BPE-C study also evaluated HOMA-IR, a measure used to assess insulin resistance. HOMA-IR changed by +2.0% with placebo, −8.33% at 650 mg/day and −16.66% at 1,300 mg/day, extending the findings beyond circulating glucose alone.
Study results reflect the specific formulations, intake levels, populations and durations evaluated. Certain BPF protocols included ascorbic acid. Findings should not be assumed to apply interchangeably across all Bergamonte® ingredient options.
Healthy glucose regulation depends on the body’s ability to respond to insulin, move glucose into cells, and use nutrients efficiently for energy. These processes are closely linked with lipid metabolism, liver function, body composition, and overall metabolic flexibility, which is why blood sugar support increasingly sits within a broader metabolic-wellness conversation.
Bergamonte® provides a useful bridge between these areas. Human research measures glucose alongside additional cardiometabolic markers, while mechanistic studies explore pathways involved in energy sensing and glucose utilization. The result is a formulation story that can extend beyond a single fasting glucose measurement.
Bergamonte® offers a broader metabolic story than single-target glucose ingredients, combining human glucose data with research on insulin responsiveness and energy metabolism.
Glucose metabolism has been evaluated alongside lipid and broader metabolic markers throughout the Bergamonte® research program. For formulators, the most relevant options are those connected to BPF® cardiometabolic research or the dedicated Full Spectrum BPE-C study examining fasting glucose and insulin sensitivity.
let’s get started
Discuss your formulation goals, intended positioning, research needs, and product-development opportunities with the HP Ingredients team.
Schedule Now
Evaluate Bergamonte® for your next product concept with a sample for formulation, compatibility, and product-development testing.
Request Now
Ready to explore how Bergamonte® can support your product pipeline? Contact HP Ingredients for samples, technical documentation, clinical research, formulation guidance, and next-step support.
Contact Us